[HTML][HTML] Immunotherapeutic strategies for head and neck squamous cell carcinoma (HNSCC): current perspectives and future prospects
L Gao, A Zhang, F Yang, W Du - Vaccines, 2022 - mdpi.com
Neoantigens are abnormal proteins produced by genetic mutations in somatic cells.
Because tumour neoantigens are expressed only in tumour cells and have immunogenicity …
Because tumour neoantigens are expressed only in tumour cells and have immunogenicity …
Immunotherapeutic Strategies for Head and Neck Squamous Cell Carcinoma (HNSCC): Current Perspectives and Future Prospects
L Gao, A Zhang, F Yang, W Du - Vaccines, 2022 - search.proquest.com
Neoantigens are abnormal proteins produced by genetic mutations in somatic cells.
Because tumour neoantigens are expressed only in tumour cells and have immunogenicity …
Because tumour neoantigens are expressed only in tumour cells and have immunogenicity …
[HTML][HTML] Immunotherapeutic Strategies for Head and Neck Squamous Cell Carcinoma (HNSCC): Current Perspectives and Future Prospects
L Gao, A Zhang, F Yang, W Du - Vaccines, 2022 - ncbi.nlm.nih.gov
Neoantigens are abnormal proteins produced by genetic mutations in somatic cells.
Because tumour neoantigens are expressed only in tumour cells and have immunogenicity …
Because tumour neoantigens are expressed only in tumour cells and have immunogenicity …
Immunotherapeutic Strategies for Head and Neck Squamous Cell Carcinoma (HNSCC): Current Perspectives and Future Prospects.
L Gao, A Zhang, F Yang, W Du - Vaccines, 2022 - search.ebscohost.com
Neoantigens are abnormal proteins produced by genetic mutations in somatic cells.
Because tumour neoantigens are expressed only in tumour cells and have immunogenicity …
Because tumour neoantigens are expressed only in tumour cells and have immunogenicity …
Immunotherapeutic Strategies for Head and Neck Squamous Cell Carcinoma (HNSCC): Current Perspectives and Future Prospects
L Gao, A Zhang, F Yang, W Du - Vaccines, 2022 - pubmed.ncbi.nlm.nih.gov
Neoantigens are abnormal proteins produced by genetic mutations in somatic cells.
Because tumour neoantigens are expressed only in tumour cells and have immunogenicity …
Because tumour neoantigens are expressed only in tumour cells and have immunogenicity …
Immunotherapeutic Strategies for Head and Neck Squamous Cell Carcinoma (HNSCC): Current Perspectives and Future Prospects.
L Gao, A Zhang, F Yang, W Du - Vaccines, 2022 - europepmc.org
Neoantigens are abnormal proteins produced by genetic mutations in somatic cells.
Because tumour neoantigens are expressed only in tumour cells and have immunogenicity …
Because tumour neoantigens are expressed only in tumour cells and have immunogenicity …